Our group has previously shown that plasma levels of IL-7 peak at the time of maximum lymphopenia and that increased IL-7 levels are associated with increased risk of grade II-IV aGVHD and reduced overall survival after HSCT (8). Here, IL7 is linked to lymphopenia.